30.04.2014
MediClin AG DE0006595101
DGAP-News: MediClin achieved a considerable sales increase and result improvements in the first quarter of 2014 against the comparable previous year's quarter
DGAP-News: MediClin AG / Key word(s): Quarter Results
MediClin achieved a considerable sales increase and result
improvements in the first quarter of 2014 against the comparable
previous year's quarter
30.04.2014 / 13:31
---------------------------------------------------------------------
MediClin achieved a considerable sales increase and result improvements in
the first quarter of 2014 against the comparable previous year's quarter
Offenburg, April 30, 2014 - In the first quarter of 2014 MEDICLIN
Aktiengesellschaft (MediClin) achieved Group sales in the amount of EUR
132.4 mill. (Q1 2013: EUR 124.5 mill.) thus being EUR 7.9 mill. or 6.4 %
above the value of the first quarter 2013. All segments contributed to
sales increase. The occupancy rate of the Group improved to 86.1 % (Q1
2013: 83.9 %) against previous year.
Material expenses and depreciation and amortisation were nearly on previous
year's level, staff costs and other operating expenses increased moderate.
In comparision with the previous year the Group operating result improved
by EUR 4.9 mill. from EUR -5.9 mill. to EUR -1.0 mill. The financial result
was EUR -1.0 mill. (Q1 2013: EUR -0,8 mill.). The result after tax
attributable to shareholders of MediClin AG of the first quarter 2014
improved by EUR 4.8 mill. from EUR -6,5 mill. to EUR -1.7 mill.
Considerable improvement of the result of the acute segment
The quarterly comparison shows that sales of the post-acute segment of EUR
74.0 mill. was EUR 3.3 mill. and sales of the acute segment of EUR 54.4
mill. was EUR 4.8 mill. or 9.8 % up against previous year's values. The
nursing care business area showed sales of EUR 3.3 mill. on previous year's
level. Higher sales and less increase of expenses than sales led to result
improvements in the two above-named segments. The segment result of
post-acute was EUR -1.8 mill. (Q1 2013: EUR -4.2 mill.), the result of the
acute segment EUR 3.1 mill. (Q1 2013: EUR 0.1 mill.).
In the first quarter of 2014 EUR 5.0 mill. (Q1 2013: EUR 4.8 mill.) were
invested in fixed assets (brutto). As of March 31, 2014 cash and cash
equivalents were EUR 11.1 mill. (31.12.2013: EUR 10.0 mill.) and the equity
ratio was 47,5 % (31.12.2013: 48.1 %).
MediClin employed on average 6,364 employees (Q1 2013: 6,352 employees),
calculated on the basis of full-time staff, in the first quarter of 2014.
Outlook
Based on the good start in the new financial year and based on sales and
result improvements coming from initiated measurements the Management Board
members assume that the target margins of the Group and the segments are
achievable.
The interim report as of March 31, 2014 will be available in German and
English from May 9, 2014 under www.mediclin.de.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungszentren (medical care units) in 11 federal states MediClin has a
total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,500 employees.
MediClin ─ a company of the Asklepios Group.
End of Corporate News
---------------------------------------------------------------------
30.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
265801 30.04.2014
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
MediClin AG ISIN: DE0006595101 können Sie bei EQS abrufen
Pflegeeinrichtungen , 659510 , MED , XETR:MED